Literature DB >> 18220905

CD34+ fibrocytes: morphology, histogenesis and function.

Peter J Barth1, Christina C Westhoff.   

Abstract

The connective tissue of virtually all human organs harbors huge amounts of resident CD34(+) fibrocytes. Recent studies have shown that CD34(+) fibrocytes derive from circulating CD14(+) monocytes. CD34(+) fibrocytes are involved in wound healing, act as antigen presenting cells and secrete a multitude of cytokines. Due to their diverse functions CD34(+) fibrocytes play a role in connective tissue diseases, pulmonary fibrosis and tumor associated stromal remodeling. Stromal remodeling precipitated by invasive carcinomas is characterized by a loss of CD34(+) expression paralleled by a gain of alpha-SMA expression in stromal cells resulting in a phenotype change from CD34(+) fibrocytes towards alpha-SMA positive myofibroblasts. This process is very stereotypic and may play an essential role in local tumor invasion and systemic dissemination, since a reduction of antigen presenting CD34(+) fibrocytes might constitute a step in escaping the hosts' immune control directed against invasive carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18220905     DOI: 10.2174/157488807781696249

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  21 in total

1.  Organ-derived coatings on electrospun nanofibers as ex vivo microenvironments.

Authors:  Sara N Fischer; Jed K Johnson; Christopher P Baran; Christie A Newland; Clay B Marsh; John J Lannutti
Journal:  Biomaterials       Date:  2010-09-26       Impact factor: 12.479

2.  Murine embryonic fibroblast cell lines differentiate into three mesenchymal lineages to different extents: new models to investigate differentiation processes.

Authors:  Khaled Dastagir; Kerstin Reimers; Andrea Lazaridis; Sabrina Jahn; Viktor Maurer; Sarah Strauß; Nadjib Dastagir; Christine Radtke; Andreas Kampmann; Vesna Bucan; Peter M Vogt
Journal:  Cell Reprogram       Date:  2014-08       Impact factor: 1.987

3.  Evaluation of Stromal Myofibroblasts in Laryngeal Dysplasia and Invasive Squamous Cell Carcinoma.

Authors:  Aylin Orgen Calli; Yelda Dere; Aysegül Sari; Fikret Dirilenoglu; Irem Onur; Kadir İmre
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-01-04

4.  Myofibroblasts are associated with the progression of scirrhous gastric carcinoma.

Authors:  Yuhiko Fuyuhiro; Masakazu Yashiro; Satoru Noda; Shinichiro Kashiwagi; Junko Matsuoka; Yosuke Doi; Yukihiro Kato; Kazuya Muguruma; Tetsuji Sawada; Kosei Hirakawa
Journal:  Exp Ther Med       Date:  2010-07-01       Impact factor: 2.447

5.  Pulsed electromagnetic fields decrease proinflammatory cytokine secretion (IL-1β and TNF-α) on human fibroblast-like cell culture.

Authors:  Ignacio Gómez-Ochoa; Pablo Gómez-Ochoa; Francisco Gómez-Casal; Encarna Cativiela; Luis Larrad-Mur
Journal:  Rheumatol Int       Date:  2010-04-07       Impact factor: 2.631

Review 6.  Corneal myofibroblast biology and pathobiology: generation, persistence, and transparency.

Authors:  Steven E Wilson
Journal:  Exp Eye Res       Date:  2012-04-20       Impact factor: 3.467

7.  CD34(+) fibrocytes in melanocytic nevi and malignant melanomas of the skin.

Authors:  Cordula Wessel; Christina C Westhoff; Katharina Nowak; Ingrid Moll; Peter J Barth
Journal:  Virchows Arch       Date:  2008-09-24       Impact factor: 4.064

8.  Increased generation of fibrocytes in thyroid-associated ophthalmopathy.

Authors:  Raymond S Douglas; Nikoo F Afifiyan; Catherine J Hwang; Kelvin Chong; Uzma Haider; Patrick Richards; Andrew G Gianoukakis; Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2009-11-06       Impact factor: 5.958

Review 9.  Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis.

Authors:  Ellen C Keeley; Borna Mehrad; Robert M Strieter
Journal:  Int J Biochem Cell Biol       Date:  2009-10-20       Impact factor: 5.085

10.  [Nephrogenic systemic fibrosis: a rare disease with grave consequences].

Authors:  J T Kielstein; M Schiffer
Journal:  Internist (Berl)       Date:  2010-01       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.